These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9083058)

  • 1. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation.
    Bouchard BA; Catcher CS; Thrash BR; Adida C; Tracy PB
    J Biol Chem; 1997 Apr; 272(14):9244-51. PubMed ID: 9083058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet factor Xa receptor.
    Tracy PB; Nesheim ME; Mann KG
    Methods Enzymol; 1992; 215():329-60. PubMed ID: 1331708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assembly of the prothrombinase complex on adherent platelets.
    Swords NA; Mann KG
    Arterioscler Thromb; 1993 Nov; 13(11):1602-12. PubMed ID: 8218101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of platelet factor Va-dependent thrombin generation by activated protein C at the surface of collagen-adherent platelets.
    Briedé JJ; Tans G; Willems GM; Hemker HC; Lindhout T
    J Biol Chem; 2001 Mar; 276(10):7164-8. PubMed ID: 11113137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
    Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
    Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.
    Hackeng TM; van 't Veer C; Meijers JC; Bouma BN
    J Biol Chem; 1994 Aug; 269(33):21051-8. PubMed ID: 8063724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations.
    Tracy PB; Eide LL; Mann KG
    J Biol Chem; 1985 Feb; 260(4):2119-24. PubMed ID: 3972783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa.
    Nicholson AC; Nachman RL; Altieri DC; Summers BD; Ruf W; Edgington TS; Hajjar DP
    J Biol Chem; 1996 Nov; 271(45):28407-13. PubMed ID: 8910465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor Xa interacts with two sites on monocytes with different functional activities.
    Worfolk LA; Robinson RA; Tracy PB
    Blood; 1992 Oct; 80(8):1989-97. PubMed ID: 1391956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase.
    Fager AM; Wood JP; Bouchard BA; Feng P; Tracy PB
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2400-7. PubMed ID: 21071689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dissection of effector cell protease receptor-1 recognition of factor Xa. Assignment of critical residues involved in antibody reactivity and ligand binding.
    Ambrosini G; Altieri DC
    J Biol Chem; 1996 Jan; 271(2):1243-8. PubMed ID: 8557657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity.
    Sims PJ; Wiedmer T; Esmon CT; Weiss HJ; Shattil SJ
    J Biol Chem; 1989 Oct; 264(29):17049-57. PubMed ID: 2793843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the role of EPR-1 or an EPR-1-like molecule in regulating factor Xa incorporation into platelet prothrombinase.
    Bouchard BA; Silveira JR; Tracy PB
    Thromb Haemost; 2001 Oct; 86(4):1133-5. PubMed ID: 11686347
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet-derived microvesicles and activated platelets express factor Xa activity.
    Holme PA; Brosstad F; Solum NO
    Blood Coagul Fibrinolysis; 1995 Jun; 6(4):302-10. PubMed ID: 7548677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction, expression, and characterization of a chimera of factor IX and factor X. The role of the second epidermal growth factor domain and serine protease domain in factor Va binding.
    Hertzberg MS; Ben-Tal O; Furie B; Furie BC
    J Biol Chem; 1992 Jul; 267(21):14759-66. PubMed ID: 1634519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of prothrombinase activity by protein S.
    van 't Veer C; Butenas S; Golden NJ; Mann KG
    Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa.
    Altieri DC
    J Biol Chem; 1994 Feb; 269(5):3139-42. PubMed ID: 8106347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
    Bukys MA; Orban T; Kim PY; Nesheim ME; Kalafatis M
    Thromb Haemost; 2008 Mar; 99(3):511-22. PubMed ID: 18327399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va pool.
    Ayombil F; Abdalla S; Tracy PB; Bouchard BA
    J Thromb Haemost; 2013 Aug; 11(8):1532-9. PubMed ID: 23710903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity.
    Sims PJ; Faioni EM; Wiedmer T; Shattil SJ
    J Biol Chem; 1988 Dec; 263(34):18205-12. PubMed ID: 2848029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.